Valsartan
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
VALSARTAN
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
The Defense Logistics Agency (DLA) Troop Support, a federal office responsible for supplying critical materials to the U.S. military and other government entities, issued a solicitation under the procurement identifier "VALSARTAN" for the supply of Valsartan tablets. Valsartan is a pharmaceutical product classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing, 2022 version) and Product Service Code 6505, which covers drugs and biologicals. The intent of this procurement was to secure a reliable source of Valsartan tablets to meet evolving government requirements, ensuring the continued availability of essential medications for supported agencies.
However, as indicated in amendment 0011 to the solicitation, the government’s requirements for Valsartan tablets have changed, resulting in the cancellation of the solicitation in its entirety. This cancellation means that no further action will be taken under this notice, and contractors should not submit proposals or inquiries regarding this specific opportunity.
The contracting activity was managed by DLA Troop Support, with primary and secondary points of contact provided for reference: Jason Wray ([email protected], 215-737-0614) and Denise Taubman ([email protected], 215-737-6877). The notice was originally posted on August 2, 2021, with a response date listed as February 13, 2020, though the solicitation status remains marked as "Active" on the SAM.gov portal. Thirteen attachments were associated with the opportunity, though no additional documents or procedural steps are indicated.
Contractors specializing in pharmaceutical manufacturing and supply, particularly those with capabilities in producing Valsartan or similar products, should note that this specific opportunity has been withdrawn due to shifting government needs. While the solicitation is no longer open, the DLA Troop Support remains a key federal buyer in the pharmaceutical sector, and future opportunities may arise as requirements evolve. Interested parties are encouraged to monitor the SAM.gov portal and maintain contact with the listed contracting officials for updates on related procurements.
For further details or to review the original notice, contractors may visit the SAM.gov opportunity page at: https://sam.gov/opp/35387d44291b4dbe846913f6ca657417/view.
Documents13